Meiji Yasuda Future Co-Creation Fund
VC Fund
Tokyo, Japan
Meiji Yasuda Future Co-Creation Fund is a corporate venture capital fund. It is co-managed by Global Brain Corporation and Meiji Yasuda Life Insurance.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Meiji Yasuda Future Co-Creation Fund invests in
Stages Meiji Yasuda Future Co-Creation Fund invests in
Countries Meiji Yasuda Future Co-Creation Fund invests in
Investment Focus
Industry
- Health Care 3 (50%)
- Medical 2 (33%)
- Information Technology 2 (33%)
- Apps 1 (17%)
- Elderly 1 (17%)
Stage
- Series B 2 (33%)
- Venture - Series Unknown 2 (33%)
- Seed 1 (17%)
- Series A 1 (17%)
Country
- Japan 5 (83%)
- United States 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Geofra develops Planning and creation of items that rejuvenate the movement of people in physical areas, regional revitalization initiatives | Venture - Series Unknown / Dec 02, 2025 | ||
| Ichirou provides digital senior care support services to connect elderly people with caretakers. It offers caretaker services for different types of support, including housework, hospital care, nursing, hospital and doctor visits, and shopping assistance. | $7.7M / Series B / Sep 11, 2025 | ||
| Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. | Venture - Series Unknown / Mar 25, 2025 | ||
| Amptalk is a software development firm specializing in operating automatic transcription and analysis of online business negotiations. | $6.6M / Series A / Dec 04, 2024 | ||
| Smart Bank is a softawre firm that has developed an application for money spending management. | $18.9M / Series B / Nov 12, 2024 | ||
| Boston Medical Sciences conducts research, prevention, and diagnostics procedures to eliminate colorectal cancer deaths. | Seed / Oct 08, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Meiji Yasuda Future Co-Creation Fund invest in?
Meiji Yasuda Future Co-Creation Fund invests primarily in Health Care, Medical and Information Technology startups, most often at Series B and Venture - Series Unknown stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Meiji Yasuda Future Co-Creation Fund last invest?
The most recent investment recorded for Meiji Yasuda Future Co-Creation Fund closed in Dec 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
